We talked about the fitness component
After approval, your customized medication is prescribed and shipped directly from a licensed 503A compounding pharmacy to your doorstep
Weight loss drugs containing GLP-1 agonists have exploded in popularity in recent years, gaining the interest of consumers for usage far beyond the FDA-approved purpose to treat type 2 diabetes and obesity
In this case, the exclusivity for the diabetes indication could end in 2027, but for the obesity indication, it could be extended until 2030, assuming Lilly is granted the extra 3 years
They may feel stronger later than expected
We'll discuss your medical history, medications, and may recommend blood work to get a complete health picture